To support brain SCFAs as a potent therapeutic agent, d-mannose remarkedly improves the gut microbiota dysbiosis in the CRS-exposure mice and enhances brain SCFA levels to resist depression by ACSS2–PPARγ–TPH2 axis. Here, ACSS2 is linked to depressive disorder.